Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2015 | $765,357 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2015 | $881,846 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Eli Lilly | North Carolina | state | 2015 | $885,684 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $900,091 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2016 | $938,710 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2016 | $1,013,383 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $1,192,386 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2015 | $1,320,134 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2015 | $1,425,876 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2016 | $4,121,650 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2016 | $4,302,041 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2015 | $7,125,021 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2015 | $8,524,608 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2015 | $12,098,272 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2017 | $2,511,374 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2017 | $2,266,743 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2018 | $2,189,941 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2018 | $1,712,426 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2017 | $467,431 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2019 | $280,119 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2018 | $254,453 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2017 | $184,344 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2017 | $143,927 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2017 | $104,949 | | tax credit/rebate |
Alcami Carolinas Corporation | Alcami | North Carolina | state | 2017 | $35,605 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2018 | $25,831 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2017 | $10,269 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2019 | $6,922 | | tax credit/rebate |
Merck Sharp & Dohme Corp. II | Merck | North Carolina | state | 2019 | $4,974,750 | | grant |
PAREXEL International, LLC | Parexel International | North Carolina | state | 2019 | $4,194,000 | | grant |
United Therapeutics Corp | United Therapeutics | North Carolina | state | 2010 | $619,566 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2010 | $367,742 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2010 | $195,448 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2010 | $107,498 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2010 | $73,000 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2010 | $68,808 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Eli Lilly | North Carolina | state | 2010 | $62,965 | | tax credit/rebate |
Pharmacia Corporation | Viatris | North Carolina | state | 2010 | $29,104 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2010 | $28,488 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2010 | $27,295 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2010 | $25,862 | | tax credit/rebate |
Serenex, Inc. | Pfizer | North Carolina | state | 2010 | $21,507 | | tax credit/rebate |
Mallinckrodt, Inc. (DE) | Mallinckrodt | North Carolina | state | 2010 | $16,925 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2010 | $14,093 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2010 | $13,009 | | tax credit/rebate |
Pozen, Inc. | Miravo Healthcare | North Carolina | state | 2010 | $9,341 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2010 | $1,517 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2017 | $200,000 | | grant |
Wyeth Holdings LLC | Pfizer | North Carolina | state | 2019 | $125,000 | | grant |
Purdue Pharma Manufacturing L. P. | Purdue Pharma | North Carolina | state | 2017 | $75,000 | | grant |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2017 | $285,887 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2017 | $15,140 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2020 | $8,689,500 | | grant |
Amgen Inc. | Amgen | North Carolina | state | 2021 | $11,612,250 | | grant |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2021 | $9,997,500 | | grant |
Eli Lilly and Company II | Eli Lilly | North Carolina | state | 2022 | $16,169,000 | | grant |
CNS Therapeutics, Inc. | Mallinckrodt | North Carolina | state | 2017 | $4,395 | | tax credit/rebate |
CNS Therapeutics, Inc. | Mallinckrodt | North Carolina | state | 2016 | $4,688 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas | GlaxoSmithKline | North Carolina | state | 2011 | $83,656 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2010 | $83,656 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2012 | $83,656 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $83,656 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2015 | $83,656 | | tax credit/rebate |
Mallinckrodt, Inc. (DE) | Mallinckrodt | North Carolina | state | 2010 | $1,742 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2018 | $57,440 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2019 | $162,248 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2020 | $168,371 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2021 | $196,021 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2022 | $200,152 | | tax credit/rebate |
United Therapeutics Corp | United Therapeutics | North Carolina | state | 2011 | $64,525 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2017 | $52,393 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2018 | $160,733 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $181,443 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2016 | $284,933 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2015 | $404,026 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2018 | $9,300 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2017 | $32,567 | | tax credit/rebate |
Allergan Sales, LLC | AbbVie | North Carolina | state | 2017 | $232,175 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2021 | $3,478 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2019 | $9,216 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2022 | $12,182 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2018 | $17,353 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2020 | $3,835 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2019 | $23,683 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2018 | $32,659 | | tax credit/rebate |
BioDelivery Sciences International, Inc. | BioDelivery Sciences International | North Carolina | state | 2018 | $1,141 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2022 | $4,871 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2021 | $6,048 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2020 | $56,926 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2019 | $78,588 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2018 | $131,371 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2017 | $148,326 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2020 | $17,084 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2018 | $92,289 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2019 | $171,670 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2020 | $9,685 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2019 | $12,415 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2021 | $23,132 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2018 | $24,721 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2022 | $47,494 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2017 | $51,414 | | tax credit/rebate |